A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma

Table 5

Kaplan-Meier analysis and ROC analysis were conducted to validate the reproducibility of five-gene model.

Prognostic factor	Group	Kaplan-Meier value	AUROCs
Age	≤57 (146)	<0.001	0.653
	>57 (157)	0.001	0.683
Stage	I, II (22)	0.018	0.625
	III (241)	<0.001	0.664
	IV (38)	<0.1	0.778